Regend Therapeutics
2 clinical trials · 2 recruiting · INDUSTRY
Trials by Regend Therapeutics
RECRUITINGPhase 1NCT07275788
A Study of REGEND003 on Patients With Type 2 Diabetes Mellitus (T2DM) and Chronic Kidney Disease (CKD)
REGEND003, which consists of human kidney progenitor cells, demonstrates promising potential in repairing kidney injury. The purpose of this study is to assess the saftey and...
Sponsor: Regend TherapeuticsEnrolling: 151 location
Type 2 Diabetes Mellitus (T2DM) and Chronic Kidney Disease (CKD)
RECRUITINGEarly Phase 1NCT07355868
Treatment of Chronic Obstructive Pulmonary Disease (COPD) by REGEND007 Cell Therapy
Chronic obstructive pulmonary disease (COPD) is the third leading cause of death worldwide with the characterization of obstructed airflow. In a large number of patients,...
Sponsor: Regend TherapeuticsEnrolling: 121 location
Chronic Obstructive Pulmonary Disease (COPD)